About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
205 genotypes with 216 annotations displayed of selected term and subterms
Searched Term: increased B cell derived lymphoma incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Aicdatm1(cre)Mnz/Aicda+
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
increased follicular lymphoma incidence J:153656
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn) 		increased B cell derived lymphoma incidence J:115076
Badtm1Sjk/Badtm1Sjk
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6)) 		increased B cell derived lymphoma incidence J:84987
Bcl2tm2.1Lbox/Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
Bcl2l11tm1.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm1.1Boui/Bcl2l11tm1.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm2.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm2.1Boui/Bcl2l11tm2.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm3.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm3.1Boui/Bcl2l11tm3.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased follicular lymphoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:86982
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:94768
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6) 		increased B cell derived lymphoma incidence J:201641
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:228288
Cd19tm1(cre)Cgn/Cd19+
Inpp5dtm1Rav/Inpp5dtm1Rav
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased follicular lymphoma incidence J:166155
increased splenic marginal zone lymphoma incidence J:166155
Cd19tm1(cre)Cgn/Cd19+
Mirc30tm1.1Rdf/Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Cd19tm1(cre)Cgn/Cd19+
Ptpn11tm1Ckq/Ptpn11+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:177285
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:70894
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		increased small lymphocytic lymphoma incidence J:88365
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:53805
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased small lymphocytic lymphoma incidence J:88365
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:63299
Cop1Gt(XR0653)1.1Wtsi/Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:178271
Crkltm1Hkp/Crkltm1Hkp
Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:83086
Cul9tm1.2Yxi/Cul9+
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
Del(14Trim13-Dleu2)4Rdf/+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Del(14Trim13-Rnaseh2b)6Rdf/+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased small lymphocytic lymphoma incidence J:179879
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased B cell derived lymphoma incidence J:81054
Dnmt1tm1(tetO-BCL2)Sjk/Dnmt1+
Tg(IghMyc)22Bri/0
Tg(MMTVtTA)1Mam/0
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:93549
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased B cell derived lymphoma incidence J:145228
Esl1NFS/N/Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Esl1SL/Kh/Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Ezh2tm1.1Nesh/Ezh2+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
Ezh2tm1.1Nesh/Ezh2tm1.1Nesh
Cd19tm1(cre)Cgn/Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased B cell derived lymphoma incidence J:244082
Fen1tm1Rak/Fen1+
(involves: 129/Sv * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:77962
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:138901
Fhittm1Tko/Fhit+
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
Flt3tm2.1Dosm/Flt3+
(B6.129(C)-Flt3tm2.1Dosm) 		increased B cell derived lymphoma incidence J:205200
Foc1NFS/N/Foc1NFS/N
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:167612
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		increased B cell derived lymphoma incidence J:185598
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:137122
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Npm1tm1Gsva/Npm1+
TgTn(pb-sb-GrOnc)#aGsva/0
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:167612
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:191824
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ) 		increased B cell derived lymphoma incidence J:181546
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:181546
H2axtm1Fwa/H2ax+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
H2axtm1Fwa/H2axtm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
Hephl1cw/Hephl1cw
(CWD/LeJ) 		increased B cell derived lymphoma incidence J:24875
Hmga1tm1Afus/Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:106702
Ifngtm1Ts/Ifngtm1Ts
Prf1tm1Sdz/Prf1tm1Sdz
(C.Cg-Prf1tm1Sdz Ifngtm1Ts) 		increased B cell derived lymphoma incidence J:77491
Ightm1(Myc)Janz/Igh+
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:160845, J:96785
Ightm1(Myc)Janz/Igh+
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:150341
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)A5Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)D3Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
Ighatm1(Myc)Janz/Igha+
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:90901
Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:98937
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:50626
Ing1Gt(OST206270)Lex/Ing1+
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
Ing1tm1Avg/Ing1tm1Avg
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:105658
Inpp5dm1Anu/Inpp5dm1Anu
(C57BL/6JAnu-Inpp5dm1Anu) 		increased B cell derived lymphoma incidence J:104190
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased small lymphocytic lymphoma incidence J:179879
Is(14)1Rdf/Is(14)1Rdf
Is(14)5Rdf/Is(14)5Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased small lymphocytic lymphoma incidence J:179879
Kat5tm1Jwl/Kat5+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Kat5tm1Jwl/Kat5+
Tg(IghMyc)22Bri/0
Trp53tm1Tyj/Trp53+
(involves: 129 * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Klrk1tm1Dhr/Klrk1tm1Dhr
Tg(IghMyc)22Bri/?
(involves: C57BL/6 * CD-1) 		increased B cell derived lymphoma incidence J:134509
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
Kmt2atm2(MLLT3)Thr/Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
Kmt2dtm1.1Kaig/Kmt2d+
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
Lig4tm1Icrf/Lig4tm1Icrf
Trp53tm1Tyj/Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)) 		increased B cell derived lymphoma incidence J:111068
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/?
(involves: 129S4/SvJae * C57BL/6 * Swiss Webster) 		increased follicular lymphoma incidence J:174270
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:189297
Mdm4tm1Glo/Mdm4+
Tg(IghMyc)22Bri/0
(involves: 129S6/SvEvTac * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:123661
Mef2btm2Rdf/Mef2b+
Tg(BCL2/IGH)M23Tjd/0
Tg(Cr2-cre)3Cgn/0
(involves: C3H/He * C57BL/6) 		increased follicular lymphoma incidence J:265465
Mef2btm2Rdf/Mef2b+
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:265465
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173230
increased follicular lymphoma incidence J:173230
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased follicular lymphoma incidence J:173671
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:223213
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:98929, J:53451
Msmr1SL/Kh/Msmr1SL/Kh
Msmr2SL/Kh/Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased B cell derived lymphoma incidence J:34941
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		increased B cell derived lymphoma incidence J:186118
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:212144
Mus81tm1Raz/Mus81tm1Raz
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:91570
Myctm1Lbox/Myc+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
Myctm1Lbox/Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:195140
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:86563
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:109522
Nhej1tm1Fwa/Nhej1tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129) 		increased B cell derived lymphoma incidence J:138774
Npm1tm1Gsva/Npm1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
Npm1tm1Ppp/Npm1+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:101494
Pcbp4Gt(D136D11)Wrst/Pcbp4+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
Pcbp4Gt(D136D11)Wrst/Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
Pdcd4tm1Yhcn/Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		increased B cell derived lymphoma incidence J:120583
Pigatm1Bsl/Y
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
Pigatm1Bsl/Piga+
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
Pknox1tm1Ngc/Pknox1+
Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased B cell derived lymphoma incidence J:192251
Plcg2tm1Jni/Plcg2tm1Jni
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:117023
Pmltm1.1Ews/Pmltm1.1Ews
(involves: 129 * 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:262172
Pmltm1Ppp/Pml+
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
Pmltm1Ppp/Pmltm1Ppp
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased B cell derived lymphoma incidence J:162378
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas) 		increased B cell derived lymphoma incidence J:162378
Polgtm1Jiha/Polg+
(involves: C57BL/6JJcl) 		increased B cell derived lymphoma incidence J:199416
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
Prdm11tm1.1Ahl/Prdm11tm1.1Ahl
Tg(IghMyc)22Bri/0
(B6.Cg-Prdm11tm1.1Ahl Tg(IghMyc)22Bri) 		increased B cell derived lymphoma incidence J:221379
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased B cell derived lymphoma incidence J:84677
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz) 		increased B cell derived lymphoma incidence J:77491
Ptpn11tm1Ckq/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:177285
Rag2tm1.1Desi/Rag2tm1.1Desi
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:168974
Rarres1tm1.2Mhl/Rarres1+
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
Rarres1tm1d(KOMP)Wtsi/Rarres1+
(involves: C57BL/6N) 		increased follicular lymphoma incidence J:324270
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ * C57BL/6) 		increased B cell derived lymphoma incidence J:95683
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased B cell derived lymphoma incidence J:168749
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased B cell derived lymphoma incidence J:223276
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:154439
S1pr2tm1Ajml/S1pr2tm1Ajml
(129S5/SvEvBrd-S1pr2tm1Ajml) 		increased B cell derived lymphoma incidence J:154439
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased B cell derived lymphoma incidence J:177486
Skiltm1Sis/Skil+
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:62174
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:193626
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:189320, J:245679
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		increased B cell derived lymphoma incidence J:162035
Suv39h1tm1Jnw/Suv39h1+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1+
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1+
Suv39h2tm1Jnw/Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1tm1Jnw
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h2tm1Jnw/Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Tbrg1tm1a(KOMP)Wtsi/Tbrg1tm1a(KOMP)Wtsi
(C57BL/6N-Tbrg1tm1a(KOMP)Wtsi) 		increased B cell derived lymphoma incidence J:225146
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased B cell derived lymphoma incidence J:89878
Tg(BCL2/IGH)#Jcre/0
Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J) 		increased small lymphocytic lymphoma incidence J:94116
Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:89786
Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:181238
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:79703
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		increased B cell derived lymphoma incidence J:117018
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:237420
increased splenic marginal zone lymphoma incidence J:237420
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop
Tg(tetO-NPM1/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop
Tg(tetO-TPM3/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C.B6-Tg(H2-L-IL6)46Kish) 		increased B cell derived lymphoma incidence J:74377
increased follicular lymphoma incidence J:74377
Tg(Igh*-Mir125b-1)5Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
Tg(Igh-HOX11)11Idd/0
(CD-1) 		increased B cell derived lymphoma incidence J:52782
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:109591
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117, J:78177
Tg(IghMyc)22Bri/0
Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:89049
Tg(IghMyc)22Bri/0
Trp53tm1Tyj/Trp53+
(involves: 129/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh) 		increased B cell derived lymphoma incidence J:131912
Tg(Igkv3-5-MYC)#Plbe/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:131912
Tg(IGL-MYC)3Hm/0
(C57BL/6N-Tg(IGL-MYC)3Hm/Nci) 		increased B cell derived lymphoma incidence J:65245
Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL) 		increased follicular lymphoma incidence J:69755
Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6J * CD-1) 		increased B cell derived lymphoma incidence J:62465
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:55022
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		increased B cell derived lymphoma incidence J:88565, J:228913
increased follicular lymphoma incidence J:88565, J:228913
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:140639
Trp53Bbl/Trp53Bbl
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased B cell derived lymphoma incidence J:104190
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
increased follicular lymphoma incidence J:169434
Trp53tm1.1Umol/Trp53tm1.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
Trp53tm1Tyj/Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Ly6e-MALT1)#Isg/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas) 		increased B cell derived lymphoma incidence J:61973
Trp53tm1Tyj/Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
Trp53tm1Yjc/Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		increased splenic marginal zone lymphoma incidence J:195018
Trp53tm2.1Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
Trp53tm2.1Umol/Trp53tm2.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
Trp53tm2Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased B cell derived lymphoma incidence J:95316
Trp53tm4Tyj/Trp53tm4Tyj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:92917
Ts(16C-tel)1Cje/0
(involves: C57BL/6J * Rb(11.16)2H * Rb(16.17)32Lub) 		increased follicular lymphoma incidence J:174270
Ts(1716)65Dn/0
(involves: C3H/HeJ * C57BL/6J * DBA/2J) 		increased follicular lymphoma incidence J:174270
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6N * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:239679
Uimc1Gt(RRN158)Byg/Uimc1Gt(RRN158)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:188388
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6) 		increased B cell derived lymphoma incidence J:191827
Ungtm1Tld/Ungtm1Tld
(Not Specified) 		increased B cell derived lymphoma incidence J:85353
WwoxGt(XG218)Byg/WwoxGt(XG218)Byg
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:132078
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		increased B cell derived lymphoma incidence J:317166
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory